롱 리드 시퀀스 시장 : 제품, 기술, 워크플로우, 최종사용자, 용도별 - 세계 예측(2025-2030년)

The Long Read Sequencing Market was valued at USD 697.72 million in 2023, expected to reach USD 859.80 million in 2024, and is projected to grow at a CAGR of 25.84%, to USD 3,487.79 million by 2030.

Long read sequencing, a cutting-edge genomic technology, enables the reading of long sequences of DNA, offering greater insight into complex genomes than short-read sequencing. The necessity for long read sequencing arises from its efficacy in identifying structural variants, repetitive regions, and haplotypes, which are often missed by traditional sequencing technologies. Its applications are vast, spanning across genomics research, clinical diagnostics, personalized medicine, and agriculture. In clinical settings, it aids in identifying genetic disorders, understanding cancer genomics, and exploring microbial diversity, while in agriculture, it is vital for crop and livestock improvement through precise genome mapping.

Market insights reveal that the growth of the long read sequencing market is driven by advancements in genomic research, increased funding from governmental bodies, and the rising prevalence of genetic disorders. However, this market faces challenges such as the high cost of equipment and sequencing processes, the complexity of data analysis, and limited standardization across platforms. Emerging opportunities in this market include the integration of AI and machine learning for data analysis, expanding applications in non-health sectors, and the rising demand for precision agriculture. To leverage these opportunities, companies should invest in the development of cost-effective sequencing solutions, enhance data interpretation capabilities, and explore underserved geographic markets.

Innovation and research in this domain could focus on improving sequencing accuracy, reducing turnaround time, and developing robust data management systems. Additionally, partnerships with academic and research institutions can drive innovation and broaden the application range. The nature of the market is competitive and rapidly evolving, with key players focusing on expanding product portfolios and strategic collaborations. Recommendations for businesses include continuous investment in R&D, staying abreast of regulatory changes, and strengthening collaborations with end-users to tailor solutions that meet specific needs. Addressing the current limitations, such as high costs and data complexity, remains crucial for sustained market growth and technological advancement.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Long Read Sequencing Market

The Long Read Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of genetic disorders globally
  • Surging awareness coupled with demand for personalized medicine
  • Increasing application in clinical sequencing and analysis
• Market Restraints
  • Technical issues and data complexity
• Market Opportunities
  • Regulatory support for product approval and initiatives towards new product launched
  • Strategic collaboration by market players for long-read sequencing developments to treat rare diseases
• Market Challenges
  • Complexities related to data storage and management

Porter's Five Forces: A Strategic Tool for Navigating the Long Read Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Long Read Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Long Read Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Long Read Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Long Read Sequencing Market

A detailed market share analysis in the Long Read Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Long Read Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Long Read Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Long Read Sequencing Market

A strategic analysis of the Long Read Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Long Read Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., BaseClear BV, Bionano Genomics, Inc., Cantata Bio, LLC., F. Hoffmann-La Roche Ltd., Future Genomics Technologies B.V., Illumina, Inc., Intel Corporation, Keygene N.V., MicrobesNG, MyJoVE Corporation, Novogene Corporation, Oxford Nanopore Technologies PLC, Quantapore, Inc., RevoluGen Limited, Sage Science, Inc., SeqLL, Inc., Takara Bio, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Long Read Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Reagents & Kits and Sample Preparation Consumables.
• Based on Technology, market is studied across Nanopore Sequencing and Single-Molecule Real-Time Sequencing.
• Based on Workflow, market is studied across Data Analysis, Pre-Sequencing, and Sequencing.
• Based on End-user, market is studied across Academic Research, Clinical Research, Hospitals & Clinics, and Pharma & Biotech Companies.
• Based on Applications, market is studied across Epigenetics, Metagenomics, RNA Sequencing, Targeted Sequencing, and Whole Genome Sequencing.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of genetic disorders globally
    • 5.1.1.2. Surging awareness coupled with demand for personalized medicine
    • 5.1.1.3. Increasing application in clinical sequencing and analysis
  • 5.1.2. Restraints
    • 5.1.2.1. Technical issues and data complexity
  • 5.1.3. Opportunities
    • 5.1.3.1. Regulatory support for product approval and initiatives towards new product launched
    • 5.1.3.2. Strategic collaboration by market players for long-read sequencing developments to treat rare diseases
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities related to data storage and management
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Emerging high-quality consumables to maintain the integrity of their research and diagnostics
  • 5.2.2. Applications: Widening application of metagenomics for high precision and detailed genomic insights
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Long Read Sequencing Market, by Product

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Reagents & Kits
  • 6.2.2. Sample Preparation Consumables
• 6.3. Instruments
• 6.4. Services

7. Long Read Sequencing Market, by Technology

• 7.1. Introduction
• 7.2. Nanopore Sequencing
• 7.3. Single-Molecule Real-Time Sequencing

8. Long Read Sequencing Market, by Workflow

• 8.1. Introduction
• 8.2. Data Analysis
• 8.3. Pre-Sequencing
• 8.4. Sequencing

9. Long Read Sequencing Market, by End-user

• 9.1. Introduction
• 9.2. Academic Research
• 9.3. Clinical Research
• 9.4. Hospitals & Clinics
• 9.5. Pharma & Biotech Companies

10. Long Read Sequencing Market, by Applications

• 10.1. Introduction
• 10.2. Epigenetics
• 10.3. Metagenomics
• 10.4. RNA Sequencing
• 10.5. Targeted Sequencing
• 10.6. Whole Genome Sequencing

11. Americas Long Read Sequencing Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Long Read Sequencing Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Long Read Sequencing Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Singapore's precision medicine program launched a long-read sequencing project to boost genetic research and clinical diagnostics
  • 14.3.2. Ambry Genetics and PacBio collaborated with UCI and GREGoR Consortium to sequence 7,000 genomes, accelerating rare disease insights and diagnostics using long-read technology
  • 14.3.3. Clinical Microbiomics AS acquired DNASense ApS to bolster long-read sequencing, expand market reach, and enhance microbiome analysis with a multi-omics approach
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. Agilent Technologies, Inc.
• 3. BaseClear BV
• 4. Bionano Genomics, Inc.
• 5. Cantata Bio, LLC.
• 6. F. Hoffmann-La Roche Ltd.
• 7. Future Genomics Technologies B.V.
• 8. Illumina, Inc.
• 9. Intel Corporation
• 10. Keygene N.V.
• 11. MicrobesNG
• 12. MyJoVE Corporation
• 13. Novogene Corporation
• 14. Oxford Nanopore Technologies PLC
• 15. Quantapore, Inc.
• 16. RevoluGen Limited
• 17. Sage Science, Inc.
• 18. SeqLL, Inc.
• 19. Takara Bio, Inc.
• 20. Thermo Fisher Scientific Inc.